SCHEMBL31567095

SCHEMBL31567095

COc1ccc(CN(c2cccc(F)n2)S(=O)(=O)c2ccc(F)c(F)c2F)c(OC)c1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
KMT2A Q03164 5/20 0.36
MAPK1 P28482 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 2/20 0.36
MEN1 O00255 3/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 1/20 0.36
OXTR P30559 1/20 0.35
ALDH1A1 P00352 4/20 0.35
HTT P42858 1/20 0.35
KDM4E B2RXH2 2/20 0.35
RORC P51449 1/20 0.34
TSHR P16473 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31018063 0.87 CYP19A1 (0.40) CYP19A1KMT2AMAPK1SMN1; SMN2GAA
SCHEMBL21783442 0.87 CYP19A1 (0.40) CYP19A1KMT2AMAPK1SMN1; SMN2GAA
SCHEMBL29669089 0.86 KDM4E (0.36) CYP19A1KMT2AMAPK1SMN1; SMN2GAA
SCHEMBL19614108 0.86 KDM4E (0.36) CYP19A1KMT2AMAPK1SMN1; SMN2GAA
SCHEMBL20238565 0.84 KMT2A (0.37) KMT2AMAPK1SMN1; SMN2GAAMEN1
SCHEMBL29669086 0.84 KMT2A (0.37) KMT2AMAPK1SMN1; SMN2GAAMEN1
SCHEMBL22590218 0.84 KMT2A (0.38) CYP19A1KMT2AMAPK1SMN1; SMN2GAA
SCHEMBL19613774 0.84 KMT2A (0.38) CYP19A1HDAC8KMT2AMAPK1SMN1; SMN2
SCHEMBL21783397 0.84 KMT2A (0.37) CYP19A1KMT2AMAPK1SMN1; SMN2GAA
SCHEMBL31018008 0.84 KMT2A (0.37) CYP19A1KMT2AMAPK1SMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096637-A1 SUBSTITUTED ARYL SULFONAMIDES FOR USE AS SODIUM CHANNEL INHIBITORS XENON PHARMACEUTICALS INC. (CA) 2025-05-08 WO disclosed